Do Asians Patients Require Only Half of the Clozapine Dose Prescribed for Caucasians? A Critical Review
Open Access
- 1 January 2020
- journal article
- editorial
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 42 (1) , 1-3
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Clinically Significant Drug Interactions with Atypical AntipsychoticsCNS Drugs, 2013
- Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Psychopharmacology, 2012
- Genetic diversity and admixture patterns in Indian populationsGene, 2012
- Influence of Environmental and Genetic Factors on CYP1A2 Activity in Individuals of South Asian and European AncestryClinical Pharmacology & Therapeutics, 2012
- PharmGKB summaryPharmacogenetics and Genomics, 2012
- Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic PolymorphismsThe Journal of Clinical Pharmacology, 2004
- Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populationsPharmacogenetics, 1997
- Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.British Journal of Clinical Pharmacology, 1994
- Pharmacokinetics and Pharmacodynamics of ClozapineClinical Pharmacokinetics, 1993
- Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and agePsychopharmacology, 1989